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The interaction between casein kinase Ia and 14-3-3 is
phosphorylation dependent
Samuel Clokie*, Helen Falconer, Shaun Mackie, Thierry Dubois and Alastair Aitken
Institute of Structural Biology, Edinburgh University, UK
Introduction
The 14-3-3 family is highly conserved over a wide
range of mammalian species, where the individual
isoforms (b, c, e, f, g, r and s) are either identical
or contain a few conservative substitutions [1]. Homo-
logues of 14-3-3 proteins have also been found in a
broad range of eukaryotes [2,3]. Almost every known
organism expresses multiple 14-3-3 isoforms [4]. 14-3-3
modulates interactions between proteins involved in
the regulation of the cell cycle, intracellular trafﬁck-
ing ⁄ targeting, signal transduction, cytoskeletal struc-
ture and transcription. The regulatory roles for 14-3-3
isoforms include nuclear trafﬁcking as well as the
direct interaction with cruciform DNA (i.e. involved in
transcription regulation) and with a number of recep-
tors, small G-proteins and their regulators. In many
cases, these proteins show a distinct preference for a
particular isoform(s) of 14-3-3 [1]. A speciﬁc repertoire
of 14-3-3 dimers may inﬂuence which interacting pro-
teins could be brought together. We have demon-
strated the preference for both mammalian and yeast
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We have previously shown that casein kinase (CK) Ia from mammalian
brain phosphorylates 14-3-3 f and s isoforms on residue 233. In the present
study, we show that CKIa associates with 14-3-3 both in vitro and in vivo.
The interaction between CKIa and 14-3-3 is dependent on CKIa phosphor-
ylation, unlike centaurin-a1 (also known as ADAP1), which binds to
unphosphorylated CKIa on the same region. CKIa preferentially interacts
with mammalian g and c 14-3-3 isoforms, and peptides that bind to the
14-3-3 binding pocket prevent this interaction. The region containing
Ser218 in this CKIa binding site was mutated and the interaction between
CKIa and 14-3-3 was reduced. We subsequently identiﬁed a second phos-
phorylation-dependent 14-3-3 binding site within CKIa containing Ser242
that may be the principal site of interaction. We also show that both ﬁssion
and budding yeast CKI kinase homologues phosphorylate mammalian and
budding yeast (BMH1 and BMH2) 14-3-3 at the equivalent site.
Structured digital abstract
l A list of the large number of protein-protein interactions described in this article is available
via the MINT article ID MINT-7264069
Abbreviations
CK, casein kinase; db-cAMP, dibutyryl-cAMP; GST, glutathione S-transferase; HEK, human embryo kidney; IVTT, in vitro transcription
translation; PKA, protein kinase A; PKC, protein kinase C; Ppase, phosphatase.
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14-3-3 isoforms to dimerize with speciﬁc partners
in vivo [5]. Interaction is most often regulated by phos-
phorylation of the interacting protein and ⁄or the 14-3-
3 isoform itself. The structures of 14-3-3 dimers [6–11]
including the site of interaction of both phospho- and
unphosphorylated motifs are known. Nonphosphory-
lated binding motifs can also be of high afﬁnity and
may show more isoform-dependence in their interac-
tion [12]. Binding of a protein through two distinct
binding motifs to a dimeric 14-3-3 may also be
essential for full interaction [13].
Budding and ﬁssion yeast each have two homo-
logues of 14-3-3 and the deletion of both is normally
lethal [14]. Deletion of a single BMH gene affects yeast
growth and cell division [15], although a particular
strain of Saccharomyces cerevisiae was found to be
viable with a double deletion of BMH1 and BMH2
[16]. The strain is, however, defective in rat sar-
coma ⁄mitogen-activated protein kinase cascade signal-
ling during pseudohyphal development.
The mammalian 14-3-3 isoforms b and f can be
phosphorylated in vivo on Ser185 [17] and, interest-
ingly, Ser185 is located in the tertiary structure adja-
cent to residue 233 [1]. Tsuruta et al. [18] have shown
that activated c-Jun N-terminal kinase promotes Bax
translocation to mitochondria through phosphoryla-
tion of 14-3-3r and f at sites equivalent to Ser185,
which led to the dissociation of Bax. The expression
of phosphorylation-defective mutants of 14-3-3
blocked c-Jun N-terminal kinase-induced Bax translo-
cation to mitochondria, cytochrome c release and
apoptosis [19].
Members of the casein kinase (CK) I family have
diverse roles, including the regulation of p53; circadian
rhythm; Wnt signalling pathway; membrane trafﬁck-
ing; regulation of centrosomes and spindle formation;
actin cytoskeleton organization; cell cycle progression;
and membrane trafﬁcking and RNA processing,
[20,21]. They co-localize in neurones with synaptic ves-
icle markers and phosphorylate some synaptic vesicle-
associated proteins. Seven isoforms from distinct genes
are expressed in mammals (CKIa, b, d, e, c1, c2, c3)
and additional CKI forms occur through alternative
splicing. CKIb is only found in bovine brain and may
be the bovine equivalent of the CKIa2 splice variant.
We identiﬁed CKIa as the brain kinase that phos-
phorylated 14-3-3 f on Thr233 [22]. 14-3-3 s and yeast
14-3-3 (BMH1 and BMH2) were also phosphorylated
on the equivalent sites [23]. In vivo phosphorylation of
14-3-3 f at this site negatively regulates its binding to c-
Raf, and may be important in Raf-mediated signal
transduction [24]. We subsequently conﬁrmed the inter-
action of a number of proteins that co-puriﬁed with
CKIa in brain by co-immunoprecipitation and afﬁnity
chromatography [25–27]. These included centaurin-a1,
comprising the phosphatidylinositol 3,4,5-triphosphate-
binding protein that associates with presynaptic vesicu-
lar structures [28]. CKIa colocalizes in neurones with
synaptic vesicle markers and phosphorylates some syn-
aptic vesicle-associated proteins [29].
We subsequently identiﬁed the site of interaction of
CKIa with centaurin-a1 in a loop region contained
within the kinase domain comprising residues 217–233
[26]. The original MS search that identiﬁed CKIa from
the co-purifying protein complex included the tryptic
peptide containing Ser218. However, the data clearly
showed no indication of phosphorylation of CKIa on
this residue. From crystallographic studies [30], the
loop region has been postulated to represent a site of
interaction with other proteins. On the basis of this
observation, we showed that a nonphosphorylated syn-
thetic peptide corresponding to this region could bind
a number of proteins from the brain, including actin,
importin-a1, importin-b, protein phosphatase 2Ac,
centaurin-a1 and HMG1 [25]. However, 14-3-3 was
not identiﬁed during those investigations.
One of the aims of the present study was to examine
the possibility that, as well as being a substrate of
CKIa, 14-3-3 could form a stable complex with CKI.
We predicted that the interaction could occur within
the interaction loop containing residue Ser218 (on the
condition that is was phosphorylated) because this
would produce a potential 14-3-3 binding motif:
RTpS218LP. The kinase domain is highly conserved
between members of the CKI family, although unique
N- and C-terminal tails characterize each isoform. An
additional aim of the study was to investigate which
CKI homologues might interact with 14-3-3 and, in
the present study, we show that CKI associates with
14-3-3 both in vitro and in vivo.
Results
Phosphorylation-dependent interaction between
14-3-3 and CKIa
To investigate whether the region 214–226 representing
the proposed ‘interaction loop’ of CKIa could bind
14-3-3, a peptide (C-FNRTpSLPWQGLKA, where pS
is phosphoserine) corresponding to this region was
coupled to Sulfolink afﬁnity beads.
Equal amounts of the phospho-CKIa peptide were
shown to bind to all 14-3-3 isoforms but preferentially
with g and c 14-3-3 isoforms (which have relatively
high sequence similarity) [1] and, to a lesser extent, to
14-3-3 r and e isoforms (Fig. 1A). Dephosphorylation
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of the peptide, by lambda phosphatase (PPase) treat-
ment resulted in a loss of interaction with all isoforms
(Fig. 1A, lanes 2). Control experiments after the incu-
bation of the PPase with the inhibitor, vanadate (VO4)
(lanes 4) indicated that the interaction is phospho-
dependent and that the effect was caused by PPase
masking the binding of the peptide to 14-3-3. More of
the g and c 14-3-3 isoforms bound to both the phos-
pho- and dephospho-peptide, with r binding approxi-
mately ﬁve-fold less (Fig. 1B). Dephosphorylation of
Ser218 reduces the binding to all of the 14-3-3 iso-
forms. The opposite result was observed with centau-
rin-a1 (Fig. 1C), which binds robustly to the
dephospho-peptide in contrast to the very low amounts
associating with the phospho-peptide. Therefore, the
interaction between centaurin-a1 and CKIa occurs
when CKIa is dephosphorylated.
14-3-3 isoforms associate with CKIa both in vitro
and in vivo
To determine the 14-3-3 isoform speciﬁcity of the
14-3-3:CKIa interaction, six isoforms of recombinant
14-3-3 were added to lysates from human embryo kid-
ney (HEK) 293 cells transfected with HA-CKIa
(Fig. 2). Recombinant glutathione S-transferase (GST)
(control) and GST-14-3-3 proteins were incubated
with the cell lysate, pulled down with glutathione
Sepharose and western blotted for CKIa using a-HA
antibodies. The results demonstrated that more CKIa
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Fig. 1. A phosphopeptide corresponding to residues 213–226 of
CKIa associates with all 14-3-3 isoforms in a phospho-dependant
manner. (A) Sulfolink beads conjugated to  20 lg of peptide corre-
sponding to residues 214–226 (C-FNRTpSLPWQGLKA) of CKIa
were incubated with all 14-3-3 isoforms (panels 1–5), washed three
times and subjected to SDS–PAGE followed by Coomassie Brilliant
Blue staining. Lane 1, untreated beads; lane 2, beads treated with
lambda phosphatase (PPase); lane 3, beads incubated with the
phosphatase inhibitor sodium orthovanadate (Na3VO4); lane 4, con-
trol PPase with the inclusion of phosphatase inhibitor (Na3VO4) to
verify that the enzyme does not interfere with binding of 14-3-3;
lane 5, amount of 14-3-3 incubated with the peptide beads (input).
(B) IMAGEJ software (http://rsbweb.nih.gov/ij/) was used to measure
the density of bands corresponding to 14-3-3 and the SD plotted
using SIGMAPLOT (Systat Software, Inc., Chicago, IL, USA). The val-
ues shown are the percentage of the intensities of 14-3-3 captured
by the peptide compared to the intensity of 14-3-3 applied to the
beads (input). These results are taken from three independent
experiments. (C) An affinity column containing phospho-CKI peptide
was prepared as in (A) and the binding of the following constructs
was analysed as before. Left panel: GST-centaurin-a1; lanes 1,
input (equal to the quantity added to the beads); lanes 2, phospho-
peptide affinity column; lane 3, phosphopeptide affinity column
after lambda phosphatase treatment. Right panel: control, GST
alone at a similar level. These results are typical of three indepen-
dent experiments.
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bound to the 14-3-3 g and c isoforms (Fig. 2A). Den-
sitometry analysis of the blot was performed to deter-
mine the binding levels between the 14-3-3 isoforms.
The amount of CKIa pulled down by equal amounts
of recombinant 14-3-3 isoforms (as judged by Ponceau
S staining; Fig. 2B) was compared with the amount of
CKIa present in 1% of the lysate. It is clear that
14-3-3 g interacts more strongly than the other iso-
forms, followed by c, b, s and f. The r isoform did
not interact at all.
To verify the isoform speciﬁcity of the 14-3-3:CKIa
interaction in vivo, a reciprocal experiment was per-
formed, whereby the CKIa binding afﬁnity to the ﬁve
14-3-3 isoforms present in abundance in HEK293 cells
was screened. This established that, in unstimulated
cells, native endogenous 14-3-3 g and c appear to
associate more than the other isoforms (Fig. 3A).
Although it is not possible to discern quantitatively the
binding afﬁnity for the g and c isoforms, as a result of
the differing titres of the antibodies, there is still a
clear difference between the isoforms. To check that
similar levels of CKIa were present in each binding
assay, a western blot was also performed using a-HA
antibodies (Fig. 3B). A control immunoprecitation is
also shown where a non-HA-immune IgG was incu-
bated in the cell lysate.
It is interesting to note that the two isoforms, 14-3-3
g and c, which were identiﬁed in the present study as
associating with CKIa to a greater degree in vitro and
in vivo, are the same isoforms identiﬁed that bind best
to the phospho Ser218 peptide (Fig. 1). Interestingly,
these two isoforms have recently been identiﬁed as
being able to bind calmodulin-dependent protein
kinase kinase, in contrast to 14-3-3 f and e [31] and, in
so doing, protect it from dephosphorylation in
HEK293 cells. The high sequence similarity between g
and c 14-3-3 (74% identity) could explain their similar
binding characteristics [1,32].
14-3-3 interacts with other mammalian CKI
isoforms
To test whether 14-3-3 was able to interact with other
CKI isoforms, CKIe was transfected into COS-7 cells
and the lysate was pulled down with GST 14-3-3 g
and GST as a control (Fig. 4). Western blotting with
a-HA antibody showed that CKIe interacted with
GST 14-3-3 g, but not the GST control (middle
panel). Because this suggests that 14-3-3 may interact
with other CKI isoforms if they contain a consensus
14-3-3 motif at the equivalent position of either resi-
due 218 or 242 (Fig. 4B), we therefore extended our
analysis to the interactions between the yeast (S. cere-
visiae) CKI homologue (HRR25) and both mamma-
lian 14-3-3 and yeast 14-3-3 homologues (BMH1 and
BMH2).
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Fig. 2. 14-3-3 isoforms associate with CKIa in vitro. (A) COS-1 cells
were transfected with HA-CKIa, the lysates were then clarified
before the addition of 10 lg of recombinant GST-14-3-3. Each sam-
ple was rotated at 4 C for 1 h before the addition of glutathione
beads. After 2 h, each pull-down was washed three times in lysis
buffer before separation by SDS–PAGE. The gel was transferred
and western blotted with a-HA. GST control lane is shown in the
far left hand lane. In the far right hand lane, 1% of the lysate that
was incubated with each 14-3-3 isoform. (B) Ponceau S staining
showing equal loading of recombinant 14-3-3 isoforms. (C) Densi-
tometry analysis of the blot in (A), showing the amount of HA-CKIa
that binds to each 14-3-3 isoform, plotted as a percentage of the
input. This experiment was carried out in duplicate with similar
results being obtained.
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The S. cerevisiae CKI homologue, HRR25, is the
principal yeast kinase that phosphorylates 14-3-3
at the site equivalent to residue 233
The cytosolic protein kinase from S. cerevisiae was
partially puriﬁed by chromatography on an SP-Sepha-
rose column. The kinase activity eluted from this
cation exchange column at a similar molarity of NaCl
( 0.4–0.5 m) as CKIa from mammalian brain [26],
indicating that the yeast protein is also a kinase with a
basic isoelectric point. The pI of HRR25 is 9.3 and the
pI of CKIa is 9.47. The peak fraction from the
SP-Sepharose column phosphorylated wild-type
6His-tagged BMH2, GST-BMH1, GST-BMH2 and
14-3-3f (Fig. 5A). There was no signiﬁcant phosphory-
lation of 14-3-3f T233A or the double phosphorylation
site mutant, 14-3-3f S185A ⁄T233A, which suggests
that residue 233 is the single site of phosphorylation
on mammalian 14-3-3 for CK1a.
To test this hypothesis, budding yeast cytosolic pro-
tein extracts were loaded onto SDS–PAGE minigels
and the gels overlaid with 6His-BMH1 wild-type and
BMH1 ⁄S237A, the equivalent site to mammalian 14-3-
3 S233. An in-gel kinase assay was then performed
with [32P]ATP ⁄Mg2+ and the gel was autoradio-
graphed. 6His-BMH1 was phosphorylated by the cyto-
solic protein extract of wild-type yeast (Fig. 5B),
whereas the BMH1 ⁄S237A mutant showed only weak
phosphorylation. 6His-BMH1 was also incubated with
a gel loaded with yeast extracts from a yeast strain
containing an HRR25 deletion. This also resulted in
weak phosphorylation of BMH1. These results indicate
that HRR25 is the budding yeast kinase that is princi-
pally responsible for phosphorylation of BMH1 at
Ser237.
The three other CKI homologues in S. cerevisiae
(YCK1-3) are largely, if not totally, membrane-associ-
ated. Of the four CKI homologues in the S. cerevisiae
genome (YCKI, YCK2, YCK3 and HRR25) [33,34],
YCK1, 2 and 3 all have a very strong consensus
sequence for prenylation and are membrane-associated,
although some studies indicate that YCK3 may only
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Fig. 3. 14-3-3 isoforms bind CKIa in vivo.
(A) Unstimulated HEK293 cells were
transfected with HA-CKIa and immunopre-
cipitated with a-HA-conjugated beads. After
extensive washing in lysis buffer, the immu-
noprecipitates were subjected to SDS–
PAGE and western blotted with antibodies
specific to each 14-3-3 isoform. Left hand
lanes show a non-immune IgG control and
the right lanes show the a-HA immunopre-
cipitation. Lane 1, 1% of the lysate in
unstimulated HEK293 cells transfected with
HA-CKI; lane 2, immunoprecipitation with a
non-immune IgG; lane 3, the a-HA immuno-
precipitation. (B) Equal amounts of CKIa
were present for the assessment of 14-3-3
immunoprecipitations. This shows a re-
probe of (A) with a-HA antibody. Lane 1,
1% of the lysate in unstimulated HEK293
cells transfected with HA-CKI; lane 2, a-HA-
conjugated agarose beads; lane 3, immuno-
precipitated HA-CKI using a-HA-conjugated
agarose beads.
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be partly membrane-associated [35]. Therefore,
HRR25 is likely to be the only CKI homologue pres-
ent in the yeast cytosolic extract.
In addition to HRR25, 6His-BMH1 can also be
phosphorylated by mammalian CKIa and by the
Schizosaccharomyces pombe homologue, Cki1
(Fig. 5C). However 6His-BMH1 ⁄S237A cannot be
phosphorylated by these kinases, again suggesting that
Ser237 is the site of phosphorylation on BMH1. A
C-terminal BMH2 deletion construct was also prepared,
where 40 residues were deleted from the C-terminus
(BMH2D40). This construct lacked residue 233
(sequence TSDIS ... onwards), where the latter serine
is the phosphorylatable residue. This construct was
also only very weakly phosphorylated by HRR25 (data
not shown), indicating that this region of the protein
contained the HRR25 phosphorylation site.
To determine whether the HRR25 kinase could
bind to the yeast BMH1, cytosolic extracts from
S. cerevisiae were passed through a GST-BMH1
afﬁnity column and, after extensive washing, the pro-
tein was eluted and incubated with BMH1 under
kinase assay conditions, with GST used as a control
(Fig. 5D). This assay shows that both 6His and
GST-BMH1 bind to HRR25 and that the control
GST does not.
Activation of protein kinase A (PKA) increases
association of 14-3-3 with CKIa in HEK 293 cells
The 14-3-3 binding motif R(S)X1,2pSX(P) is generally
a good consensus for a number of kinases, including
PKA, Ca2+-calmodulin kinase II, protein kinase C
(PKC) and AKT [36]. scansite analysis (http://scan-
site.mit.edu) of the CKIa sequence revealed a PKA or
PKC phosphorylation site around the possible 14-3-3
binding motif at Ser242.
From an analysis of over 400 experimentally veriﬁed
PKA sites in the Phospho.ELM database (http://phos-
pho.elm.eu.org/),  58% have two basic residues at
expected positions; 35% have one; and 7% have no
basic residue at position-3. It is clear therefore that
many actual PKA substrates have a consensus similar
to that found around the Ser218 site on CKIa (i.e.
just one basic residue located near the amino termi-
nus).
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Fig. 4. 14-3-3 g binds to the CKIe isoform
in vitro. (A) HA-CKIe was transfected into
COS-7 cells, lysed and clarified by centrifu-
gation. A sample of 1% of the COS-7 lysate
transfected with HA-CKIe is shown in the
left hand panel. Equal amounts of GST or
GST 14-3-3 g were incubated with the
lysate for 2 h. GST or GST-14-3-3 g was
recovered by glutathione beads and sepa-
rated by SDS–PAGE. Western blotting with
a-HA antibody revealed the presence of
CKIe in the GST-14-3-3 pull-down, but not
the GST control (middle panel). Ponceau S
staining revealed that similar amounts of
GST and GST-14-3-3 g were incubated with
the lysate shown in the right hand panel.
The results are taken from two independent
experiments. (B) Sequence alignment
around the potential 14-3-3 binding region in
CKI isoforms.
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The phosphatase inhibitor, NaF was added to CKIa
expressed as a 35S-labelled in vitro, transcription, trans-
lation (IVTT) product and binding assays were per-
formed using GST-14-3-3 f and GST as a control.
Binding was shown to increase on treatment with
NaF, indicating a phospho-dependent binding mecha-
nism. After incubation with NaF, two- to three-fold
more CKIa associated with 14-3-3 than in a control
incubation without NaF (Fig. 6A, compare lane 4 with
6). Densitometry was used to quantify the increase
(Fig. 6C). A Coomassie Brilliant Blue stain on the
right shows that similar amounts of GST and GST-14-
3-3 were incubated with the IVTT reaction (Fig. 6B).
A similar experiment was carried out in which recom-
binant PKA was added to the assay after IVTT syn-
thesis, along with NaF; however, no additional
increase was seen (data not shown).
Because we had established that 14-3-3 g and 14-3-3
c associated more strongly than other isoforms with
CKIa in mammalian cells, for future binding experi-
ments using cell culture, we focussed on the association
of these endogenous 14-3-3 isoforms with CKIa. To
determine whether PKA could stimulate (either directly
or indirectly) phosphorylation of Ser218 on CKIa, and
thus induce association with 14-3-3, HA-CKIa was
transfected into HEK293 cells and PKA was activated
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T233A; lane 7, 14-3-3 f S185A ⁄ T233A. The SP-sepharose purification was carried out on two separate occasions. The kinase activity, which
eluted in three or four major fractions was shown to phosphorylate both the yeast 14-3-3 homologues (but not the S237A mutants; data not
shown). On each occasion, one of the peak fractions was subsequently used to phosphorylate the constructs indicated in each lane.14-3-3 f
wild-type (lane 5) was assayed in duplicate in two separate lanes, one of which has been excised for clarity. (B) Cytosolic protein extracts
from budding yeast were loaded onto SDS–PAGE minigels and were overlaid with 6His-BMH1 wild-type and BMH1 ⁄ S237A. An in-gel kinase
assay was then performed with [32P]ATP ⁄Mg2+ and the gel was autoradiographed to identify whether active kinase is present. Lane 1, 6His-
tagged BMH1, S237A; lane 2, 6His-tagged BMH1 wild-type; lane 3, 6His-tagged BMH1 phosphorylated by cytosolic protein extract from
yeast HRR25 deletion mutant strain. This is a representative example of similar assays carried out on three separate occasions with similar
results being obtained. (C) Left hand panel: purified His-tagged recombinant yeast 14-3-3, 6His-BHM1, wild-type (wt) and Ser>Ala mutant
were phosphorylated by mammalian CK1a and by the S. pombe homologue, CKi1 (Millipore) using an in vitro kinase assay. Lanes 1 and 3,
6His-tagged BMH1 wild-type; lanes 2 and 4, 6His-tagged BMH1, S237A. This assay was performed in duplicate with similar results being
obtained. Right hand panel: in-gel protein kinase assay of yeast cytosolic protein extract loaded on a number of lanes in a separate SDS–
PAGE minigel, containing 6His-BMH1 wild-type and 6His-BMH1 S237A. The kinase assay was carried out with [32P]ATP ⁄Mg2+ and autora-
diographed. For clarity, only one lane per gel is shown. Lane 5, 6His-BMH1 wild-type; lane 6, 6His-BMH1 ⁄ S237A. This assay is a control
showing the specificity of the S. cerevisiae kinase for the S237 site. This has been demonstrated many times with both BMH1 and BMH2
GST- and 6His constructs. (D) An aliquot of the bound material was eluted from an affinity column of GST-BMH1 and an in-gel kinase assay
was carried out. Lane 1, phosphorylation of 6His-BMH1; lanes 2 and 3, phosphorylation of GST-BMH1 (in duplicate); lane 4, kinase activity
of protein eluted from control beads (from an affinity column of GST alone), assayed with GST-BMH1 as substrate. This is a representative
example of binding assays carried out on two separate occasions with similar results being obtained.
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with the addition of dibutyryl-cAMP (db-cAMP). A
transient increase in association with 14-3-3 g was
observed (Fig. 7A) after 10 min. Loading controls
(Fig. 7B–D) indicate that equal amounts of 14-3-3 g
and b-actin were present in the lysate and that equal
amounts of CKIa were present in each immunoprecipi-
tation. A repeat of this experiment with shorter time
points (2 and 5 min) showed maximal binding at an
even earlier time point of 5 min (data not shown). This
time scale is consistent with previous studies examining
PKA activation. Zhang et al. [37] were able to observe
PKA activation by forskolin or db-cAMP in real time
using ﬂuorescence resonance energy transfer and a spe-
cially created construct containing 14-3-3 fused to a
ﬂexible loop region containing a perfect PKA phos-
phorylation site within a 14-3-3 binding motif. Binding
of 14-3-3 to CKIa decreased, even below the level of
original binding, after 60 min, possibly as a result of
phosphatase activity and ⁄or translocation of CKIa
after 14-3-3 binding.
CKIa expressed by IVTT associates with 14-3-3 g
in a phosphorylation-dependent manner
After observing that PKA activation by db-cAMP
increased the association between 14-3-3g and CKIa,
intact wild-type CKIa was expressed by IVTT and
incubated with GST-14-3-3g in the presence of
db-cAMP. The phosphorylation state of CKIa within
the reticulocyte lysate was also increased by incubating
the lysate with phosphatase inhibitor. These results
(Figs 7 and 8) suggest that a basal level of interaction
is possible between 14-3-3g and CKIa, which may be
phosphorylation dependent. The interaction between
CKIa and 14-3-3g was not completely abolished by a
site-directed mutant S218A (Fig. 8) and further IVTT
analysis showed that constructs lacking residues 217–
233 still showed some interaction with 14-3-3g (data
not shown). This ﬁnding is in contrast to the interac-
tion of constructs containing this region with centau-
rin-a1 [26]. We therefore searched in this region for
other potential 14-3-3 binding motifs. Because the
serine at 242 (KKMpS242TP) is a good consensus, we
made the S242A mutation of this residue and a double
S ﬁ A mutant of both residues 218 and 242.
Figure 8 shows that the S218A mutation caused a
signiﬁcant reduction in 14-3-3g binding compared to
wild-type CKIa, whereas S242A and double
S218 ⁄ 242A mutation reduced 14-3-3g binding almost
entirely. This experiment was repeated in COS-7 cells
with similar results being obtained (data not shown).
The S242A mutant showed almost complete loss of
interaction, suggesting that, in these cell lines, the as
yet unknown physiologically relevant kinase(s) were
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Fig. 6. 14-3-3 binds CKIa in a phosphoryla-
tion-dependent manner. (A) CKIa was pro-
duced by IVTT in the reticulocyte lysate (see
Materials and methods) for 90 min, and
then incubated with and without NaF for an
additional 30 min at 30 C before being
tested for interaction with 14-3-3. Lanes 1
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Interaction between CKIa and 14-3-3 S. Clokie et al.
6978 FEBS Journal 276 (2009) 6971–6984 ª 2009 The Authors Journal compilation ª 2009 FEBS
relatively inactive and that the basal level of phosphor-
ylation of Ser218 was low. Therefore, this indicates
that the phosphorylation of S242 is more crucial for
14-3-3g binding than S218.
Discussion
By contrast to a number of other brain proteins
including centaurin-a1, 14-3-3 did not co-purify with
CKIa and we did not observe an association between
14-3-3 and an afﬁnity column comprising the unphos-
phorylated peptide corresponding to this region of
CKI [25]. In the present study, we conﬁrm that the
interaction between 14-3-3 and CKIa is phosphoryla-
tion-dependent, with increased binding with the phos-
phorylated peptide. By contrast, centaurin-a1, which is
a phosphatidylinositol 3,4,5-trisphosphate binding pro-
tein involved in the modulation of vesicular trafﬁcking
and actin cytoskeleton organization, and comprising a
GTPase-activating protein for ARF6 [38], binds only
when the peptide has been dephosphorylated using
PPase treatment.
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cAMP. An immunoprecipitation was performed in the nontransfect-
ed cells using CKIa antibody to check that 14-3-3g interacted
endogenously with CKIa. The third lane shows unstimulated cells
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10 min induced the greatest amount of 14-3-3:CKIa association;
thereafter, the association diminished. (B, C) One percent of the
lysate was western blotted with a-14-3-3 g and with a-b-actin. (D)
The immunoprecipitated HA-CKIa blot was stripped and re-probed
with a-HA after blotting with a-14-3-3 g (lower panels). These
results are typical of three independent experiments.
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14-3-3 g and c isoforms bind most tightly to both
the phospho-peptide and the dephosphopeptide and
have been identiﬁed both in vitro and in vivo as bind-
ing most strongly to CKIa (Figs 1–3). The highly con-
served nature of 14-3-3, in particular within the
binding pocket, suggests that very subtle binding dif-
ferences must exist to explain exactly how the same
ligand can preferentially bind different 14-3-3 isoforms.
The interaction of CKIa most probably occurs
through contact with the basic pocket within 14-3-3 g,
and is potentially further mediated through different
contacts within the 14-3-3 dimer, perhaps aiding the
observed isoform binding speciﬁcity. The crystal struc-
ture(s) of CKI have identiﬁed this region as being part
of an unstructured loop that could be involved in
protein interactions. Although unlikely, mutations to
alanine (at positions 218 and 242) could have altered
the local structure of CKIa in such a way as to
decrease binding to 14-3-3, not just as a result of the
removal of a phosphorylatable residue.
We have shown that Ser233 on 14-3-3s is the residue
phosphorylated by BCR in vitro [39]. By contrast to
CKIa, BCR phosphorylates the 14-3-3 s isoform to a
greater extent than 14-3-3 f. CKIe also interacted with
14-3-3 g (Fig. 4). It may therefore be concluded that
14-3-3 interacts with other CKI isoforms if they con-
tain a consensus 14-3-3 motif at the equivalent position
of either residue 218 or 242. However, this region may
well have a speciﬁc repertoire of binding molecules
because recent studies found that this region in CKId
could not interact with MAP1A [40], suggesting it is
not the only interaction region within CKI.
The C-terminal regions of CKId [41] and CKIe [42]
can be hyperphosphorylated, causing autoinhibition of
the isoforms, presumably by binding into or obscuring
the active site such that it cannot access substrate.
CKIe contains an almost identical sequence around
Ser218 compared to CKIa and a totally conserved
sequence around Ser242. The fact that CKIe binds
14-3-3 shows that the extended C-terminal in CKIe
does not interfere with binding. As noted earlier, this
region is highly conserved throughout CKI isoforms;
therefore, it is likely that other CKI isoforms will also
interact through the region around Ser218.
There are many examples in the literature of 14-3-3
binding in an isoform-speciﬁc manner (e.g. Cbl, chlo-
ride intracellular channel 4, insulin-like growth factor-
1, nuclear factor of activated T cells 3, PKCf and
Par3a), although the issue of isoform binding speciﬁc-
ity is often not fully addressed in the literature. The
data reported in the present study suggest that a bind-
ing preference exists for CKIa, and that the isoform
14-3-3 r was unable to bind intact CKIa from cell
extracts. This 14-3-3 isoform shows some structural
differences [43] and has a well-characterized speciﬁc
role in the regulation of the cell cycle. The expression
of 14-3-3 r is induced after DNA damage by the tran-
scription factor of tumour suppressor gene p53. 14-3-3
r then arrests the cell cycle at the G2 ⁄M checkpoint
by sequestering CdC2 into the cytoplasm [44]. Another
example of a speciﬁc role for an isoform is provided
by the zeta isoform, whose down-regulation has been
shown to suppress anchorage-independent growth of
lung cancer cells [45].
Addition of the phosphatase inhibitor NaF or modu-
lation of PKA activity in HEK293 cells affected the
amount of 14-3-3 association with CKIa, suggesting
that the interaction can be regulated in vivo, even if not
directly by PKA, and opens up possibilities for future
studies into the regulation of CKI:14-3-3 association.
The interaction between 14-3-3 g and CKIa was not
completely abolished by mutating Ser218 on CKIa and
further analysis revealed that Ser242 is a binding site for
14-3-3. The results obtained from both cell transfection
and immunoprecipitation studies indicate that CKIa is
phosphorylated on both Ser218 and Ser242 and inter-
acts in a phosphorylation-dependent manner with 14-3-
3 isoforms. The CKIa mutant S218A had a reduced
ability to associate with 14-3-3, whereas mutation of
S242A reduced the binding almost completely. The dou-
ble mutation completely abolished binding and had the
same effect as the single S242A mutation; therefore, two
possibilities are apparent. One is that Ser242 is the
major site of the 14-3-3 phospho-dependent interaction
and the other is that a S ﬁ A mutation at this position
changes the local structure or conformation of CKI in
such a way as to decrease the binding afﬁnity. This
could be a result of the different binding afﬁnities of 14-
3-3 for these sites or different levels of kinase activity
and ⁄or kinase selectivity toward these sites.
A possible scenario could be that each 14-3-3 mono-
mer of the 14-3-3 dimer could bind a phosphorylated
residue of Ser218 and Ser242 simultaneously, after
phosphorylation by PKA ⁄PKC or another kinase.
Such ‘bidentate’ binding has previously been observed
for molecules such as Raf, BAD and Cbl [9,46].
A further possibility is that the Ser242 interaction is
behaving like a ‘gatekeeper’, binding 14-3-3 ﬁrst, and
then allowing Ser218 (with presumably lower afﬁnity) to
bind into the other binding pocket of the 14-3-3 dimer,
according to the ‘gatekeeper hypothesis’ [47]. This may
help to explain the 14-3-3 isoform binding speciﬁcity
because this region of CKI isoforms around Ser242 is
slightly less conserved than around Ser218 (Fig. 4B).
Computer docking simulations were performed using
zdock software (http://zdock.bu.edu/software.php)
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with respect to the known structures of a truncated CKI
[30] and 14-3-3 [6,7], aiming to determine whether a
dimeric 14-3-3 could bind CKI in a conformation where
each subunit contacts a phospho-S218 and phospho-
S242. The distances calculated between residues corre-
sponding to Ser218 and the Ser242 peptide backbone
and residues within the phosphate binding pocket of 14-
3-3 suggested that these may be too great for phospho-
S218 and phospho-S242 to bind in the phospho-binding
pockets of the same 14-3-3 dimer (data not shown), and
a fairly large structural movement might be required to
accommodate simultaneous binding to CKI.
In conclusion, we have shown that CKIa interacts
with 14-3-3 in a phosphorylation-dependent manner.
This was demonstrated both in vitro and in vivo using
HEK293 cells, Cos-1 cells, Cos-7 cells and in yeast as
well as sheep brain (data not shown). However, the
phosphorylation state of CKIa in vivo remains to be
determined. We have previously shown that PKC iso-
forms phosphorylate centaurin-a1 and reduce the asso-
ciation with CK1a [48]. Therefore, the difference in
phosphorylation dependence of the interactions that
we have demonstrated in the present study has impor-
tant implications for the respective roles of centaurin-a
and the 14-3-3 isoforms in the regulation of signalling
through CKI isoforms.
Materials and methods
Materials
All chemicals and reagents were obtained from Sigma-
Aldrich (St Louis, MO, USA), except for ATP (Redivue
adenosine 5¢ [32P]trisphosphate[cP], triethylammonium salt),
which was obtained from GE Healthcare (Chalfont St Giles,
UK). Pre-stained protein marker was obtained from New
England Biolabs (Ipswich, MA, USA). Protease inhibitor
tablets were obtained from Roche (Basel, Switzerland). The
catalytic subunit of PKA was obtained from Merck (San
Diego, CA, USA). The S. pombe CKI homologue, CKi1
(P40233) was obtained from Millipore (Billerica, MA, USA).
Molecular biology
The cDNAs for all 14-3-3 isoforms used for the peptide
afﬁnity experiments were obtained from various sources.
14-3-3b (P39146), is an IMAGE clone (4843961 ⁄
gi14060448) and was subcloned from the supplied vector
(pOTB7) PCR with two oligonucleotides: 5¢-GATC
GAATTCATGACAATGGATAAAAGTGAGCTGGTA-3¢
and 3¢-GATCGTCGACTTAGTTCTCTCCCTCCCCAG-5¢,
creating an EcoR1 and a Sal1 restriction site, respectively
(underlined). The PCR product was inserted into pGEX-
4T1 (GE Healthcare), creating an N-terminal GST fusion.
14-3-3g (Q04917), 14-3-3c (P61981) and 14-3-3r (P31947)
were a gift from Henrik Leffers (University Department of
Growth and Reproduction, Rigshospitalet, Copenhagen,
Denmark), and the g and c clones were present as an
N-terminal GST-fusion in the vector pGEX-2TK (GE
Healthcare). The 14-3-3r was subcloned from the vector
pGPT-delta 6 using the oligonucleotides 5¢-GATCGAAT
TCATGGAGAGAGCCAGTCTGATC-3¢ and 3¢-GATCGT
CGACTCAGCTCTGGGGCTCCT-5¢ creating an EcoR1
site and a Sal1 site, respectively (underlined). The PCR
product was inserted into pGEX-4T1. 14-3-3f (P63104) was
obtained from a human cDNA library and was produced
as an N-terminal GST fusion in the pGEX-2T vector. 14-3-
3e (P62260) was produced as an N-terminal MBP fusion
from a rat cDNA (accession m84416). Human 14-3-3s
(P27348) was obtained from a previous study [49]. BMH1
(P29311) and BMH2 (P34730) were cloned as described pre-
viously [5]. CKIe (P49674) was a gift from David Virshup
(Johns Hopkins University School of Medicine, UH, USA)
and was cloned into pS752. CKIa (P67828) was a gift from
Peter Roach (Department of Biochemistry and Molecular
Biology, Indiana University School of Medicine, Indiana-
polis, IN, USA) and centaurin-a (Q63629) was obtained
from Anne Theibert (University of Alabama at Birming-
ham, Birmingham, AL, USA). All cDNAs were checked by
sequencing both strands (Cytomyx, Cambridge, UK).
Recombinant protein purification
All GST-14-3-3 fusion cDNAs were transformed into Esc-
herichia coli BL21 (DE3) pLysS competent cells (Merck),
using the appropriate antibiotic. The cells were grown at
37 C until a D600 of 0.9 was reached, then induced using
isopropyl thio-b-d-galactoside from MP Biomedicals (Irvine,
CA, USA) for 3.5 h at 30 C, with shaking. The same proce-
dure was used for the MBP-14-3-3e fusion but with the addi-
tion of glucose at 2 gÆL)1. Cell pellets, re-suspended in lysis
buffer [NaCl ⁄Pi, 1 mm phenylmethanesulfonyl ﬂuoride,
1 mm EDTA, 1 mm dithiothreitol, protease inhibitor tablet
(Roche) and 0.1% Triton] were lysed by sonication and clar-
iﬁed by centrifugation. The GST fusion protein was removed
from the lysate using glutathione Sepharose 4B beads (GE
Healthcare), and then the beads were washed extensively
and the 14-3-3 cleaved off using thrombin (Sigma-Aldrich).
Immobilization of phosphopeptide
A synthetic peptide corresponding to residues 214–226
(CFNRTpSLPWQGLKA, where pS is phosphoserine) of
CKIa was covalently attached to ‘Sulpholink’ gel (Pierce,
Rockford, IL, USA) according to the manufacturer’s
instructions, through the cysteine residue, as introduced for
this purpose, at the N-terminus. These were divided into
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two equal amounts, with one aliquot being dephosphoryl-
ated by incubation with k phosphatase and the other left
phosphorylated. The beads were then incubated with
HEK293 cell lysate for 2 h at 4 C, with gentle rotation
and, after extensive washing (ﬁve washes) in lysis buffer,
the CKI-peptide ‘pull-downs’ were re-suspended in Lae-
mmli buffer. Subsequently, four-ﬁfths of each ‘pull-down’
was analysed by SDS–PAGE, followed by Coomassie
Brilliant Blue staining and the remaining one-ﬁfth was
separated by SDS–PAGE followed by transfer for western
blotting. The presence of 14-3-3 was conﬁrmed by western
blotting using anti-PAN 14-3-3 serum, which recognizes all
14-3-3 isoforms. Four percent of the lysate originally
applied to the beads was loaded in a separate lane.
IVTT and pull-down assays
CKIa constructs were expressed in vitro using a T7 TNT
coupled transcription ⁄ translation reticulocyte lysate (Pro-
mega, Madison, WI, USA). The 50 lL reactions were per-
formed in accordance with the manufacturer’s instructions in
a reaction mixture containing [35S]methionine (GE Health-
care) for 90 min at 30 C. Samples were made up to
200 lL with binding buffer (20 mm Tris, pH 7.4, 100 mm
NaCl, 10% glycerol, 1 mm dithiothreitol, 1% Nonidet-P40)
and incubated for 15 min at 30 C, with GST or GST-14-3-
3f. A further 300 lL of binding buffer containing glutathi-
one beads was added to the reactions and incubated at
room temperature for an additional 1 h. The beads were
washed ﬁve times with 1 mL of binding buffer and electro-
phoresed on 15% SDS-PAGE. After staining ⁄ destaining,
the gels were incubated for 30 min with Amplify (GE
Healthcare), dried and exposed to ﬁlm.
Western blotting and antibodies
Western blot analysis was performed with the ECL detection
system (GE Healthcare) using antibodies speciﬁc to each 14-
3-3 isoform as described previously [32]. Western blots could
be stripped and re-probed up to three times, after retesting
the blots with the secondary antibody to ensure that the pre-
vious antibody had been removed. Antibodies to HA were
obtained from Sigma-Aldrich (clone HA-7), anti-CKIa was
from Santa Cruz (Santa Cruz, CA, USA) and anti-b-actin
was from Millipore. Horseradish peroxidase coupled anti-
rabbit (Bio-Rad, Hercules, CA, USA) and anti-mouse
(Sigma-Aldrich) secondary sera were used. Samples were
then analysed by SDS-PAGE, followed by autoradiography.
Yeast DNA manipulation
The yeast strain used was YPH252. DNA manipulations
were performed in E. coli DH5a2. The BMH1 Ser>Ala
237 phosphorylation site mutant was generated by replacing
the wild-type sequence GAGATGTCCGAGT with GA
GATGGCCGAGT and the BLE1D40 deletion strain was
produced as described previously [5]. The HRR25 (P29295)
deletion strain was obtained from Brenda Andrews (Uni-
versity of Toronto, Canada) [50]
Extraction of protein from yeast
At least 5 · 108 cells per sample were harvested by centrifu-
gation. The cell pellets were then frozen on dry ice in
1.5 mL Eppendorf tubes and could be stored at )70 C.
Further manipulations were carried out on ice or at 4 C.
To the cell pellet, 100 lL of lysis buffer (25 mm Tris, pH
7.4, 100 mm NaCl, 10 mm EDTA, 1 mm dithiothreitol, 1%
Triton X-100, 5% glycerol, 50 mm b-glycerophosphate,
20 mm NaF, 1 mm Na3VO4, 1 mm sodium pyrophosphate,
with protease inhibitors; 1 mm phenylmethanesulfonyl ﬂuo-
ride and 1 mm each aprotinin, leupeptin, pepstatin A,
chymostatin, 50 lgÆmL)1 TLCK and 100 lgÆmL)1 TPCK)
were added. Sufﬁcient acid-washed glass beads (0.5mm
diameter; Sigma-Aldrich) were added to ﬁll up the depth of
liquid and tubes were vortexed vigorously for 1 min. Fluid
was removed from the beads, which were then washed once
with another 100 lL of lysis buffer. The lysis buffer extract
was combined in a fresh tube and centrifuged in a micro-
fuge for 3 min to remove insoluble material.
Purification of HRR25 kinase from yeast
The cytosolic protein kinase HRR25, from S. cerevisiae was
partially puriﬁed by chromatography on an SP-Sepharose
column as described previously [23].
Kinase assays
Twenty picomol of puriﬁed proteins were tested for their
ability to be phosphorylated in vitro by CK1a as described
previously [29] or by CKi1 (Millipore). Reactions were
stopped by the addition of electrophoresis sample buffer
and analysed on SDS ⁄PAGE. Gels were stained with
Coomassie Brilliant Blue and autoradiographed.
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